REVELATION BIOSCIENCES, INC.
Cash Flow Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-8.4M | $-2.7M | $-2.2M | $-2.6M | $-1.4M | $6.2M | $-1.2M | $-1.2M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $7.2K | $6.3K | $6.3K | $6.3K | $6.3K | $6.3K | $6.3K | $6.3K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $32.1K | $32.1K | $32.1K | $32.1K | $59.4K | $32.1K | $32.4K | $40.7K |
| Net Cash from Operating Activities | $-2.5M | $-2.8M | $-2.0M | $-1.7M | $-2.0M | $-1.6M | $-947.5K | $-1.7M |
| Investing Activities | ||||||||
| Capital Expenditures | $0 | $19.2K | — | $0 | $0 | $0 | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | $-19.2K | — | $0 | $0 | $0 | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $0 | $5.4M | $0 | $0 | $15 | $14.0M | $5.0K | $4.5M |
| Net Change in Cash | — | — | — | — | — | — | — | — |
| Free Cash Flow | $-2.5M | $-2.9M | — | $-1.7M | $-2.0M | $-1.6M | — | — |